parkinson glutathione oxidative ipsc crispr CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease Glutathione S-transferase: A keystone in
Glutathione S transferase: A keystone in Parkinson's disease pathogenesis and therapy ScienceDirect Patient Specific iPSC Derived Astrocytes Contribute to Non Cell Autonomous Neurodegeneration in Parkinson's Disease ScienceDirect Genome editing in Parkinson's disease: Unlocking therapeutic avenues through CRISPR Cas systems ScienceDirect Frontiers Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



